Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Noncontrolling Interest
Beginning Balance at Dec. 31, 2021	$ 306,055	$ 187	$ 888,547	$ (582,694)	$ 15
Beginning Balance, Shares at Dec. 31, 2021		187,193,613
Net loss	(40,817)
Net loss attributable to Alignment Healthcare, Inc.	$ (40,817)	$ 0	0	(40,817)	0
Issuance of common stock upon vesting of restricted stock units	383,508
Forfeitures, shares		(163,064)
Equity-based compensation	$ 28,047	$ 0	28,047	0	0
Ending Balance at Mar. 31, 2022	293,285	$ 187	916,594	(623,511)	15
Ending Balance, Shares at Mar. 31, 2022		187,414,057
Beginning Balance at Dec. 31, 2022	$ 239,302	$ 187	970,180	(732,241)	1,176
Beginning Balance, Shares at Dec. 31, 2022	187,280,015	187,280,015
Net loss	$ (37,371)	$ 0	0	(37,284)	(87)
Net loss attributable to Alignment Healthcare, Inc.	(37,284)
Noncontrolling interest attributable to subsidiary	30				30
Issuance of common stock upon vesting of restricted stock units		1,204,777
Issuance of common stock upon vesting of restricted stock units values	1	$ 1
Forfeitures	0	$ 0	0	0	0
Forfeitures, shares		(9,514)
Equity-based compensation	21,978	$ 0	21,978	0	0
Ending Balance at Mar. 31, 2023	$ 223,940	$ 188	$ 992,158	$ (769,525)	$ 1,119
Ending Balance, Shares at Mar. 31, 2023	188,475,278	188,475,278